K-numberK241269
Device namemXACT Total Prosthesis Offcenter, mXACT Total Prosthesis Center and mXACT PRO Total Prosthesis Kit
ApplicantMED-EL Elektromedizinische Geräte GmbH
Product codeETA
Device classClass II
Decision dateJan 17, 2025
DecisionSubstantially Equivalent
Regulation874.3495
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The mXACT Total Prosthesis devices are passive middle ear implants (ossicular replacement prostheses) designed to restore sound transmission from the tympanic membrane to the oval window by replacing the ossicles. They are implanted in patients with congenital or acquired ossicular chain defects or inadequate hearing from previous middle ear surgery, provided the stapes footplate is present and functional. The devices are single-use, sterile implants intended for use by qualified ENT surgeons.

Technological characteristics

The MED-EL devices use medical-grade titanium construction with a cannulated stem for stability on the stapes footplate and are available in fixed (Offcenter and Center variants) or adjustable (PRO variant with snap-mechanism) functional lengths ranging from 3.0–7.0 mm. Key differences from predicates include a slit-headplate design allowing optional bending and a snap-closing mechanism for length adjustment, versus the predicate's plastic deformation headplate. All devices share identical headplate dimensions, shaft staging, biocompatibility, and MRI conditional compatibility at 1.5T, 3.0T, and 7.0T.

Test standards cited

Testing followed EN ISO 10993 (biocompatibility), EN ISO 11137-1 and 11137-2 (sterilization validation with gamma irradiation to <10⁶ SAL), EN ISO 11607 (shelf-life and packaging validation), ASTM F2119, F2052, and F2182 (MRI environment compatibility), and mechanical testing.

Substantial equivalence argument

The devices are substantially equivalent because they treat the same ossicular chain defects using identical intended use, method of attachment (cannulated stem placement on stapes footplate), materials (medical-grade titanium), and similar design principles as the predicate devices. Clinical data from 92 patients showed 53.3% achieving postoperative air-bone gap closure ≤20 dB, comparable to the state-of-the-art benchmark of 48.3–57.4%, with low adverse event rates (4 total in 102 patients, including only 1 device dislocation and 3 revision surgeries). The snap-closing headplate mechanism represents an improvement over the predicate's requirement for special surgical closing tools, confirmed through non-clinical testing, thus raising no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →